Unlike the clinical situation, in which the retinal disorder is present prior to administration of the anti-VEGF therapy, healthy rabbits receive an initial anti-VEGF treatment at baseline of the study, several days prior to induction of vascular leakage with the administration of VEGF. This evidence concerns the gene VEGFA and retinal disorder.